AbbVie Enters Obesity Drug Market with $2.2B Gubra Licensing Deal
AbbVie, a leading biopharmaceutical company, has taken a significant step
How AI is Revolutionizing Antibiotic Discovery to Combat Drug-Resistant Bacteria
Antibiotic resistance poses a significant global health threat, rendering many
Metsera’s Weight-Loss Drug MET-097i Shows Strong Clinical Results
Obesity remains a critical public health challenge in the United
Michigan-Based Biotech Startup CircNova Secures $3.3M Seed Funding to Advance AI-Driven Circular RNA Therapies
CircNova, a Michigan-based biotechnology startup, has successfully raised $3.3 million
Illumina’s Market Struggles Deepen as U.S.-China Tensions Escalate
Illumina, a prominent biotech firm specializing in gene-sequencing technology, is
Breaking Barriers: BioArctic’s Blood-Brain Transport Technology and Its Impact on Neurological Drug Delivery
BioArctic, a Swedish biotechnology company renowned for its innovative approach
Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion
Merck KGaA, Darmstadt, Germany, is reportedly in advanced negotiations to
Light-Based Microcapillary Monitoring Expands Precision in Biotechnology
Microcapillary technology, particularly light-based microcapillary monitoring, represents a significant advancement
Draupnir Bio Raises €12 Million to Advance Oral Protein Degraders Targeting Extracellular Proteins
Draupnir Bio, a cutting-edge biotechnology company, has successfully raised €12
Novo Holdings Leads $100 Million Series C Financing for Asceneuron
Novo Holdings has led a $100 million Series C financing
German Biotech CatalYm Raises $150 Million for Phase 2b Cancer Studies
CatalYm, a German biotech company specializing in cancer immunotherapy, has
Myricx Bio’s NMTi-ADCs Achieve Tumor Regression in Preclinical Trials
The field of cancer treatment is on the cusp of
Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion
Eli Lilly and Company, a global leader in pharmaceutical development,
Brisbane Biotech Gelomics Raises $2.2 Million in Pre-Seed Funding
In a significant stride towards ethical biomedical advancements, Brisbane-based biotech
Alumis IPO Priced at $16, Targets $210M Funding
Alumis, a clinical-stage immunology biotech company, has priced its downsized
Unlocking New Frontiers: How Generative AI is Transforming Protein Design and Drug Discovery
Abstract This report explores the transformative impact of generative artificial
Manulife and World Economic Forum Launch Longevity Innovation Challenge
Manulife and World Economic Forum Launch Longevity Innovation Challenge In
Impact of Space Travel on Immune Function and Potential Countermeasures
Abstract Space travel poses significant challenges to human health, particularly
UroGen Aims to Raise $107M to Advance Innovative Obesity and Bladder Cancer Therapies
Introduction Overview of UroGen: UroGen Pharma Ltd., headquartered in Princeton,
Diamond Biofund Becomes First Biotech VC Firm Listed on Taiwan Stock Exchange
Introduction: Diamond Biofund has recently achieved a groundbreaking milestone by
Marea Biotech Secures $190 Million for Heart Disease Research
Introduction Marea Biotech, a pioneering company in the biotech industry,
Illumina Faces Potential $7 Billion Loss from Forced Grail Sale: An Analysis
1. Introduction Background on Illumina and Grail Illumina, Inc. is
Revolutionizing Dairy: How Biotech Companies are Producing Milk Without Cows
Abstract This report explores the emerging field of animal-free dairy
EU Sets New Goals for Advancing Biotechnology and Biomanufacturing
Executive Summary The EU Biotech and Biomanufacturing Initiative is a
MOST POPULAR
